FIELD: medicine.
SUBSTANCE: invention also describes methods of treatment or reduction of such malfunctions severity, including introduction into patient's organism of compound according to claimed invention or composition, which contains it.
EFFECT: method is useful for treatment or reduction of difficulty, for example, Alzheimer's disease.
20 cl, 2 ex, 22 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOUNDS APPLICABLE FOR NEURODEGENERATIVE DISORDERS | 2006 |
|
RU2461562C2 |
| ISOINDOLINE COMPOSITIONS AND METHODS OF TREATING NEURODEGENERATIVE DISEASE | 2015 |
|
RU2692258C2 |
| AMYLOID-BINDING AGENTS | 2010 |
|
RU2517174C2 |
| COMPOSITIONS FOR TREATMENT OF NEURODEGERATIVE DISEASES | 2018 |
|
RU2792562C2 |
| AZAANTRACYCLINE DERIVATIVES AND PHARMACEUTICAL COMPOSITION | 1996 |
|
RU2159245C2 |
| SUBSTITUTED N-ARYLBENZAMIDES AND RELATED COMPOUNDS FOR TREATING AMYLOID DISEASES AND SYNUCLEINOPATHY | 2005 |
|
RU2381213C2 |
| ANTHRACYCLIN DERIVATIVES | 1995 |
|
RU2159619C2 |
| COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING BETA-AMYLOID DISEASES AND SYNUCLEINOPATHIES | 2009 |
|
RU2501792C2 |
| COMPOUNDS, COMPOSITIONS AND METHODS FOR CEREBRAL HEALTH PROTECTION IN NEURODEGENERATIVE DISORDERS | 2010 |
|
RU2576032C2 |
| RADIOPHARMACEUTICAL COMPOSITION | 2008 |
|
RU2475267C2 |
